Interferon-alpha

DBCAT004225Pharmacologic class

One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3... A DrugBank category of 6 drugs. 6 of them are approved.

Drugs: Interferon alfa
Interferon alfa-2a
Interferon alfa-2b
Interferon alfa-n3
Peginterferon alfa-2b
Ropeginterferon alfa-2b

What you can answer from here — as of September 06, 2018

6DrugsEach linked to its full drug card

Listed above

4Drug targetsEvery drug–target pair in the class, with bond type

456Marketed productsAcross the regions we cover, with dosage forms and routes

7Routes of administrationHow the drugs in this class are given

Which targets do Interferon-alpha share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account